We are live on ! Find out more
NRS

Neville Rodie & Shaw Portfolio holdings

AUM $1.55B
1-Year Est. Return 46.95%
This Fund
S&P 500
This Quarter Est. Return
+1.57%
1 Year Est. Return
+46.95%
3 Year Est. Return
+114.59%
5 Year Est. Return
+149.24%
10 Year Est. Return
+497.97%
AUM
$924M
AUM Growth
-$461K
Cap. Flow
-$13.7M
Cap. Flow %
-1.49%
Top 10 Hldgs %
30.49%
Holding
268
New
8
Increased
62
Reduced
122
Closed
10

Top Buys

Rank Stock Value
1
BKU icon
Bankunited
BKU
+$10.4M
2
GBDC icon
Golub Capital BDC
GBDC
+$4.16M
3
NEM icon
Newmont
NEM
+$631K
4
FLS icon
Flowserve
FLS
+$439K
5
EOG icon
EOG Resources
EOG
+$409K

Top Sells

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$3.34M
2
XOM icon
ExxonMobil
XOM
+$3.09M
3
EMC
EMC CORPORATION
EMC
+$2.46M
4
IBM icon
IBM
IBM
+$2.2M
5
TD icon
Toronto Dominion Bank
TD
+$1.56M

Sector Composition

Rank Sector Weight
1 Energy 20.32%
2 Industrials 19.18%
3 Healthcare 13.63%
4 Technology 11.77%
5 Financials 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XOM icon
1
ExxonMobil
XOM
$643B
$74.2M 8.03%
759,379
-32,400
-4% -$3.09M
SLB icon
2
SLB Ltd
SLB
$73.2B
$41.6M 4.51%
427,071
-668
-0.2% -$60.4K
JNJ icon
3
Johnson & Johnson
JNJ
$613B
$30M 3.24%
305,049
-5,057
-2% -$469K
AAPL icon
4
Apple
AAPL
$4.46T
$25.5M 2.76%
1,329,216
-29,372
-2% -$559K
BP icon
5
BP
BP
$114B
$20M 2.16%
508,214
-5,925
-1% -$234K
GE icon
6
GE Aerospace
GE
$383B
$18.9M 2.04%
152,074
-6,023
-4% -$744K
MRK icon
7
Merck
MRK
$316B
$18.5M 2.01%
342,370
-10,634
-3% -$551K
WFC icon
8
Wells Fargo
WFC
$266B
$17.9M 1.94%
360,016
-650
-0.2% -$30.3K
IBM icon
9
IBM
IBM
$213B
$17.6M 1.9%
95,526
-12,476
-12% -$2.2M
GOOG icon
10
Alphabet (Google) Class C
GOOG
$4.56T
$17.5M 1.9%
632,201
-13,972
-2% -$407K
QCOM icon
11
Qualcomm
QCOM
$159B
$17.4M 1.88%
220,726
+1,344
+0.6% +$101K
TMO icon
12
Thermo Fisher Scientific
TMO
$213B
$17.2M 1.86%
143,213
-4,095
-3% -$487K
PCP
13
DELISTED
PRECISION CASTPARTS CORP
PCP
$16.1M 1.75%
63,862
-2,523
-4% -$653K
CBI
14
DELISTED
Chicago Bridge & Iron Nv
CBI
$16M 1.73%
183,654
+1,638
+0.9% +$133K
NSC icon
15
Norfolk Southern
NSC
$75.6B
$15.4M 1.67%
158,716
-2,140
-1% -$198K
NEE icon
16
NextEra Energy
NEE
$181B
$14.8M 1.61%
620,660
-15,000
-2% -$340K
ESRX
17
DELISTED
Express Scripts Holding Company
ESRX
$14.7M 1.59%
195,315
-2,056
-1% -$154K
J icon
18
Jacobs Solutions
J
$16.4B
$13.5M 1.46%
257,243
-4,474
-2% -$230K
DD
19
DELISTED
Du Pont De Nemours E I
DD
$13.3M 1.44%
208,749
-6,954
-3% -$425K
DIS icon
20
Walt Disney
DIS
$170B
$11.5M 1.25%
143,770
-4,826
-3% -$374K
INTC icon
21
Intel
INTC
$459B
$11.5M 1.24%
445,229
-5,866
-1% -$146K
CVX icon
22
Chevron
CVX
$385B
$11.4M 1.23%
95,536
-1,472
-2% -$171K
BKU icon
23
Bankunited
BKU
$3.4B
$11.1M 1.2%
+318,695
New +$10.4M
MDY icon
24
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.7B
$11M 1.19%
43,797
-197
-0.4% -$48.3K
PVH icon
25
PVH
PVH
$4.09B
$10.8M 1.17%
86,750
+365
+0.4% +$44.9K

Similar funds

Neville Rodie & Shaw's Q1 2014 Portfolio in Review

As of Q1 2014, Neville Rodie & Shaw held 268 positions worth $924M, down 0.05% from $924M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Neville Rodie & Shaw's Q1 2014 filing shows 8 new, 62 increased, 122 reduced and 10 closed positions. Its largest new stake was Bankunited: 318,695 shares worth $11.1M. The largest sale was Novo Nordisk, an estimated $3.34M.

By sector, the portfolio is most concentrated in Energy at 20% of assets, down from 21% a quarter earlier, followed by Industrials and Healthcare.

  • Neville Rodie & Shaw's largest Q1 2014 buy was Bankunited: 318,695 shares worth $11.1M.
  • Neville Rodie & Shaw added most to Golub Capital BDC in Q1 2014, an estimated $4.16M increase.
  • Neville Rodie & Shaw's biggest Q1 2014 reduction was Novo Nordisk, cutting an estimated $3.34M.
  • Neville Rodie & Shaw fully exited VanEck Oil Services ETF in Q1 2014, selling an estimated $1.21M.
  • Neville Rodie & Shaw's ten largest holdings make up 30% of its $924M portfolio in Q1 2014.
  • Neville Rodie & Shaw opened 8 new positions and closed 10 in Q1 2014.
  • Neville Rodie & Shaw's portfolio value fell 0.05% quarter-over-quarter to $924M.

Based on Neville Rodie & Shaw's 13F filing for Q1 2014, filed 8 Apr 2014.